AI assistant
Snap-on Inc — Director's Dealing 2024
Dec 19, 2024
30335_dirs_2024-12-19_dd9dd503-9e77-47ad-bab4-f04f97ad8d0e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Snap-on Inc (SNA)
CIK: 0000091440
Period of Report: 2024-12-18
Reporting Person: Pagliari Aldo John (Sr VP - Finance & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-12-18 | Common Stock | M | 10000 | $144.69 | Acquired | 107577.4161 | Direct |
| 2024-12-18 | Common Stock | S | 438 | $343.0457 | Disposed | 107139.4161 | Direct |
| 2024-12-18 | Common Stock | S | 500 | $344.274 | Disposed | 106639.4161 | Direct |
| 2024-12-18 | Common Stock | S | 780 | $345.7439 | Disposed | 105859.4161 | Direct |
| 2024-12-18 | Common Stock | S | 160 | $347.2265 | Disposed | 105699.4161 | Direct |
| 2024-12-18 | Common Stock | S | 2008 | $348.0659 | Disposed | 103691.4161 | Direct |
| 2024-12-18 | Common Stock | S | 2223 | $348.7991 | Disposed | 101468.4161 | Direct |
| 2024-12-18 | Common Stock | S | 800 | $349.7225 | Disposed | 100668.4161 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-12-18 | Stock Option (Right to Buy) | $144.69 | M | 10000 | Disposed | 2025-02-12 | Common Stock (10000) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $138.03 | 2026-02-11 | Common Stock (35000) | 35000 | Direct |
| Stock Option (Right to Buy) | $168.70 | 2027-02-09 | Common Stock (36000) | 36000 | Direct |
| Stock Option (Right to Buy) | $161.18 | 2028-02-15 | Common Stock (26052) | 26052 | Direct |
| Stock Option (Right to Buy) | $155.92 | 2029-02-14 | Common Stock (23500) | 23500 | Direct |
| Stock Option (Right to Buy) | $155.34 | 2030-02-13 | Common Stock (23500) | 23500 | Direct |
| Stock Option (Right to Buy) | $189.89 | 2031-02-11 | Common Stock (14986) | 14986 | Direct |
| Stock Option (Right to Buy) | $211.67 | 2032-02-10 | Common Stock (11252) | 11252 | Direct |
| Stock Option (Right to Buy) | $249.26 | 2033-02-09 | Common Stock (7850) | 7850 | Direct |
| Stock Option (Right to Buy) | $269.00 | 2034-02-15 | Common Stock (7106) | 7106 | Direct |
| Restricted Stock Units | $ | 2025-02-10 | Common Stock (1924) | 1924 | Direct |
| Restricted Stock Units | $ | 2026-02-09 | Common Stock (1793) | 1793 | Direct |
| Restricted Stock Units | $ | 2027-02-15 | Common Stock (1533) | 1533 | Direct |
| Performance Units | $ | Common Stock (3847) | 3847 | Direct | |
| Performance Units | $ | Common Stock (3586) | 3586 | Direct | |
| Performance Units | $ | Common Stock (3065) | 3065 | Direct |
Footnotes
F1: The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2023.
F2: Includes 33.4576 shares acquired under a dividend reinvestment plan.
F3: This transaction was executed in multiple trades at prices ranging from $342.69 to $343.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F4: This transaction was executed in multiple trades at prices ranging from $344.16 to $344.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F5: This transaction was executed in multiple trades at prices ranging from $345.32 to $346.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F6: This transaction was executed in multiple trades at prices ranging from $346.46 to $347.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F7: This transaction was executed in multiple trades at prices ranging from $347.48 to $348.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F8: This transaction was executed in multiple trades at prices ranging from $348.48 to $349.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F9: This transaction was executed in multiple trades at prices ranging from $349.49 to $350.26. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
F10: Option fully vested.
F11: Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2023.
F12: Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
F13: 1 for 1.
F14: The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
F15: If the Company achieves certain goals over the 2022-2024 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F16: If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
F17: If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.